NCT05919303 is a clinical trial of CT Scan in Obstuctive Jaundice, sponsored by Shree Birendra Hospital.

Who is sponsoring NCT05919303?

NCT05919303 is sponsored by Shree Birendra Hospital.

What drugs are being tested in NCT05919303?

Interventions in NCT05919303: CT Scan.

What condition does NCT05919303 study?

NCT05919303 studies Obstuctive Jaundice, Radiological Correlation of Obstructive Jaundice.

Is NCT05919303 still recruiting?

NCT05919303 is currently completed. Last updated 26 June 2023.

Last reviewed 2023-06-26 · How we verify

NCT05919303

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Multidetector Computed Tomography (MDCT) Evaluation of Obstructive Jaundice: A Cross-sectional Study From a Tertiary Hospital of Nepal

Completed Last updated 26 June 2023

What this trial tests

trial testing CT Scan in Obstuctive Jaundice in 30 participants. Completed in 10 October 2020.

Timeline

8 October 2019

Primary endpoint
7 October 2020

10 October 2020

Quick facts

Lead sponsor	Shree Birendra Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	8 October 2019
Primary completion	7 October 2020
Estimated completion	10 October 2020
Sites	1 location across Nepal

Drugs / interventions tested

CT Scan — full drug profile →

Conditions studied

Obstuctive Jaundice — all drugs for Obstuctive Jaundice →
Radiological Correlation of Obstructive Jaundice — all drugs for Radiological Correlation of Obstructive Jaundice →

Sponsor

Shree Birendra Hospital

Who can join

Eligibility, any sex, with Obstuctive Jaundice or Radiological Correlation of Obstructive Jaundice. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was done to evaluate the diagnostic statistics of MDCT and its features in the assessment of obstructive jaundice in reference to surgical or histopathological diagnosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of CT Scan

Trials testing the same drug.

NCT06199479 — Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain Malignancie · Phase 1 · recruiting
NCT04933617 — Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas · Phase 1 · terminated
NCT04946552 — Sympathetic Activation in Obesity · NA · completed
NCT04716907 — Thymic Function in Patients With COVID-19 · completed
NCT04518722 — CT-Based Changes in Bone and Marrow Among Patients on Oral Steroids · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05919303 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shree Birendra Hospital
Last refreshed: 26 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05919303.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing